MedTrace Logo

Role of the Neonatal Fc Receptor for IgG in the Pathophysiology of Lupus

NCT03896373 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2021-02-24

No results posted yet for this study

Summary

This study evaluates the expression of the neonatal fc receptor (FcRn) in white blood cells and antigen-presenting cells (APC) in active lupus patients compared to inactive lupus patients and control to investigate if it's upregulated or not.

Conditions

  • Lupus Erythematosus, Systemic

Interventions

OTHER

Blood samples

Blood samples

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • Valérie GOUILLEUX, PhD · University Hospital, Tours

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-17
Primary Completion
2020-10-18
Completion
2020-10-18

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03896373 on ClinicalTrials.gov